Home » ST. JUDE MEDICAL ANNOUNCES FDA AND EUROPEAN CE MARK APPROVALS OF TENDRIL ST PACEMAKER LEAD
ST. JUDE MEDICAL ANNOUNCES FDA AND EUROPEAN CE MARK APPROVALS OF TENDRIL ST PACEMAKER LEAD
September 20, 2006
St. Jude Medical, Inc. announced U.S. Food and Drug Administration (FDA) and European CE Mark approvals of the new Tendril(R) ST model 1788 lead, a new pacemaker lead whose thin structure is designed for easier implantation.
St. Jude Medical (http://phx.corporate-ir.net/test/phoenix.zhtml?c=73836&p=IROL-SingleRelease_print&t=NewsRelease&id=906852&highlight=)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct